Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Palmitate and Stearate are Increased in the Plasma in a 6-OHDA Model of Parkinson's Disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Maternal Metabolome in Pregnancy and Childhood Asthma or Recurrent Wheeze in the Vitamin D Antenatal Asthma Reduction Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post-hoc analysis of a randomized crossover trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

INTRODUCTION: Parkinson's disease (PD) is the second most common neurodegenerative disorder, without any widely available curative therapy. Metabolomics is a powerful tool which can be used to identify unexpected pathway-related disease progression and pathophysiological mechanisms. In this study, metabolomics in brain, plasma and liver was investigated in an experimental PD model, to discover small molecules that are associated with dopaminergic cell loss.

METHODS: Sprague Dawley (SD) rats were injected unilaterally with 6-hydroxydopamine (6-OHDA) or saline for the vehicle control group into the medial forebrain bundle (MFB) to induce loss of dopaminergic neurons in the substantia nigra pars compacta. Plasma, midbrain and liver samples were collected for metabolic profiling. Multivariate and univariate analyses revealed metabolites that were altered in the PD group.

RESULTS: In plasma, palmitic acid (q = 3.72 × 10-2, FC = 1.81) and stearic acid (q = 3.84 × 10-2, FC = 2.15), were found to be increased in the PD group. Palmitic acid (q = 3.5 × 10-2) and stearic acid (q = 2.7 × 10-2) correlated with test scores indicative of motor dysfunction. Monopalmitin (q = 4.8 × 10-2, FC = -11.7), monostearin (q = 3.72 × 10-2, FC = -15.1) and myo-inositol (q = 3.81 × 10-2, FC = -3.32), were reduced in the midbrain. The liver did not have altered levels of these molecules.

CONCLUSION: Our results show that saturated free fatty acids, their monoglycerides and myo-inositol metabolism in the midbrain and enteric circulation are associated with 6-OHDA-induced PD pathology.

OriginalsprogEngelsk
Artikelnummer31
TidsskriftMetabolites
Vol/bind9
Udgave nummer2
ISSN2218-1989
DOI
StatusUdgivet - 13 feb. 2019

ID: 56600127